anti-MTA2 antibody product blog
Tags: Antibody; Monoclonal Antibody; MTA2; anti-MTA2 antibody;
The MTA2 mta2 (Catalog #MBS2541988) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The MTA2 Monoclonal Antibody reacts with Human, Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s MTA2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA (EIA).WB: 1:500-1:5000
IHC: 1:50-1:500
IF: 1:20-1:200. Researchers should empirically determine the suitability of the MTA2 mta2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The MTA2 mta2 product has the following accession number(s) (GI #1060099369) (NCBI Accession #NP_001317221.1) (Uniprot Accession #O94776). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the MTA2 Monoclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of HeLa cells using MTA2 Monoclonal Antibody at dilution of 1:1000)
Metastasis-associated protein MTA2, also named as MTA1L1 or PID, is a 668 amino acid protein, which contains one BAH domain, one ELM2 domain, one GATA-type zinc finger and one SANT domain. MTA2 localizes in the nucleus and is widely expressed in many tissues. MTA2 may be involved in the regulation of gene expression as repressor and activator.
Immunogen: Fusion protein of MTA2. Buffer: PBS with 0.02% sodium azide, 50% glycerol, PH7.3
Conjugation: Unconjugated. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MTA2 are readily searchable from our website. Different antibodies against the same target such as MTA2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. MTA2 also interacts with the following gene(s): CHD3, CHD4, GATAD2A, GATAD2B, HDAC1, HDAC2, MBD2, MBD3, RBBP4, RBBP7. Adenocarcinoma, Anemia, Disease Models, Animal, Fetal Growth Retardation, Hyperplasia, Inflammation, Liver Diseases, Lung Neoplasms, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to MTA2 Monoclonal Antibody.